CL Comera Life Sciences Holdings, Inc. Stock: price and management transactions · United States · SEC (Form 4)Source id SEC:comera-life-sciences-holdings-inc-8ec701 US · SEC (Form 4) Mcap US$3.1k Follow the Comera Life Sciences Holdings, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €3k. The latest transaction was filed on 28 November 2023 (Acquisition). Among the most active insiders: Cherington Charles. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 November 2023
All Executives31 Thresholds0 Prospectus0 Other0
Declarations 31 total
▲ EVP & CFO · Executives · 27 Nov 2023
10,000 shares @ US$0.0708 1.2% of flow Common Stock SEC:0001062993-23-021522:0
Canonical exit: 25 Feb 2024 (T+90) ● Director · Executives · 15 Nov 2023
3,113 shares 0Common Stock SEC:0001062993-23-021111:0
58,680 shares @ €0.4755 16.0% of flow Common Stock SEC:0001948079-23-000003:0
Canonical exit: 10 Dec 2023 (T+90) 2,053,789 shares @ €0.4755 41.8% of flow Common Stock SEC:0001104659-23-099800:0
Canonical exit: 10 Dec 2023 (T+90) 880,195 shares @ €0.4649 17.5% of flow Common Stock SEC:0001104659-23-095433:0
Canonical exit: 29 Oct 2023 (T+90) ▲ Chief Scientific Officer · Executives · 14 Aug 2023
20,000 shares @ US$0.6252 100.0% of flow Common Stock SEC:0001062993-23-016524:0
Canonical exit: 12 Nov 2023 (T+90) ● Director · Executives · 11 Aug 2023
6,636 shares 0Common Stock SEC:0001062993-23-016521:0
136,919 shares @ €0.4648 36.5% of flow Common Stock SEC:0001948079-23-000002:0
Canonical exit: 29 Oct 2023 (T+90) ▲ Director · Executives · 4 Jan 2023
13,513 shares @ €1.1662 100.0% of flow Common Stock SEC:0001062993-23-003492:0
Canonical exit: 4 Apr 2023 (T+90) ▲ Director · Executives · 4 Jan 2023
33,783 shares @ €1.1662 100.0% of flow Common Stock SEC:0001062993-23-003510:0
Canonical exit: 4 Apr 2023 (T+90) ▲ Director · Executives · 4 Jan 2023
10,979 shares @ €1.1662 100.0% of flow Common Stock SEC:0001062993-23-003495:0
Canonical exit: 4 Apr 2023 (T+90) ▲ Director · Executives · 4 Jan 2023
20,270 shares @ €1.1662 100.0% of flow Common Stock SEC:0001062993-23-003485:0
Canonical exit: 4 Apr 2023 (T+90) ▲ Director · Executives · 4 Jan 2023
81,081 shares @ €1.1662 48.6% of flow Common Stock SEC:0001062993-23-003511:0
Canonical exit: 4 Apr 2023 (T+90) ▲ Director · Executives · 4 Jan 2023
6,756 shares @ €1.1662 100.0% of flow Common Stock SEC:0001062993-23-003497:0
Canonical exit: 4 Apr 2023 (T+90) 67,567 shares @ €1.1662 45.2% of flow Common Stock SEC:0001948079-23-000001:0
Canonical exit: 4 Apr 2023 (T+90) 743,243 shares @ €1.1662 37.1% of flow Common Stock SEC:0000899243-23-001182:0
Canonical exit: 4 Apr 2023 (T+90) ◆ Director · Executives · 4 Jan 2023
20,270 shares @ €1.1662 50.0% of flow Common Stock SEC:0001062993-23-000612:0
◆ Director · Executives · 4 Jan 2023
33,783 shares @ €1.1662 50.0% of flow Common Stock SEC:0001062993-23-000609:0
◆ Director · Executives · 4 Jan 2023
6,756 shares @ €1.1662 50.0% of flow Common Stock SEC:0001062993-23-000611:0
◆ Director · Executives · 4 Jan 2023
13,513 shares @ €1.1662 50.0% of flow Common Stock SEC:0001062993-23-000607:0
◆ Director · Executives · 4 Jan 2023
81,081 shares @ €1.1662 32.7% of flow Common Stock SEC:0001062993-23-000610:0
◆ Director · Executives · 4 Jan 2023
10,979 shares @ €1.1662 50.0% of flow Common Stock SEC:0001062993-23-000608:0
3,000 shares @ €1.38 2.4% of flow Common Stock SEC:0001948079-22-000002:0
Canonical exit: 6 Feb 2023 (T+90) 3,316 shares @ €1.5568 0.2% of flow Common Stock SEC:0001062993-22-021051:0
Canonical exit: 18 Jan 2023 (T+90) 4,253 shares @ €1.6451 0.3% of flow Common Stock SEC:0001062993-22-020905:0
Canonical exit: 12 Jan 2023 (T+90) 25 of 31 declarations
Load more (6 remaining) 关于 Comera Life Sciences Holdings, Inc. Comera Life Sciences Holdings, Inc. 是一家专注于开发生物制药解决方案的公司。该公司旨在通过创新技术改进治疗方法。